BACK

Renal > RCC

Clinical trial information


Select trial for more information

Area under investigation,RCC=true

NCT04522323 trial overview

Tumor

Advanced RCC

Trial Identifier

NCT04522323

Phase

Ib

Stage

Advanced RCC

Regimen

Volrustomig + axitinib; volrustomig + lenvatinib

Visit ct.gov
Go

Some compounds herein refer to selected AstraZeneca pipeline products still under development. AstraZeneca pipeline products are investigational products and, as such, are not approved by the US Food & Drug Administration (FDA), the European Medicines Agency (EMA) or any other regulatory agency for the uses under investigation. Information regarding these investigational products should, under no circumstances, be regarded as a recommendation for their use or of their safety or efficacy.

This site is intended for US Healthcare Professionals.

Veeva ID: Z4-84958 US-109129 DE-92568 Last Updated October 20263/26
©2026 AstraZeneca. All rights reserved.